Stimulation of Growth Hormone Release by Intraventricular Administration of 5HT or Quipazine in Unanesthetized Male Rats
E. Vijayan, L. Krulich, Samuel M. McCann
Abstract
E. Vijayan, L. Krulich, Samuel M. McCann
Abstract
Intraventricular injection of 5HT (4 and 20 μg) in unanesthetized, unrestrained male rats fitted with permanent intrajugular cannulas for withdrawal of blood samples caused a dose-related elevation of plasma GH levels. Similar effects were also observed following intraventricular injection of the serotonin receptor agonist, quipazine. The GH-releasing effect of both drugs was abolished by a serotonin receptor blocker, methysergide. It is concluded that activation of the central serotoninergic system stimulates GH secretion in the rat.
OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Intraventricular injection of 5HT (4 and 20 μg) in unanesthetized, unrestrained male rats fitted with permanent intrajugular cannulas for withdrawal of blood samples caused a dose-related elevation of plasma GH levels. Similar effects were also observed following intraventricular injection of the serotonin receptor agonist, quipazine. The GH-releasing effect of both drugs was abolished by a serotonin receptor blocker, methysergide. It is concluded that activation of the central serotoninergic system stimulates GH secretion in the rat.
Key concepts: Quipazine, Methysergide, Endocrinology, Internal medicine, Serotonergic, Serotonin, 5-HT receptor, Agonist